• Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates

    Tuesday March 24th 2020

  • Dr. Matthias Friebe joins Camel-IDS as acting Chief Technology Officer.

    Tuesday March 24th 2020

  • ElmediX wil coronavirus stoppen door patiënten gecontroleerd op te warmen.

    Tuesday March 24th 2020

  • ViroVet to support COVID19 research and sample testing

    Monday March 23rd 2020

  • Janssen start productie van desinfecterende handvloeistof om ziekenhuistekorten aan te vullen in de strijd tegen het coronavirus

    Monday March 23rd 2020

  • InnoSer continues to deliver critical in-vivo and in-vitro services

    Friday March 20th 2020

  • Alzheimer risk genes converge on microglia

    Thursday March 19th 2020

  • Corona update: flanders.bio

    Wednesday March 18th 2020

  • Your news here?

  • Een ontstekingsremmend proteïne

    Wednesday March 18th 2020

  • Statement on Corona virus (COVID-19) in regard to flanders.bio events

    Wednesday March 11th 2020

  • Biocartis kondigt nieuw immuno-oncologie project aan met Bristol-Myers Squibb voor de registratie van de Idylla™ MSI test in China

    Thursday March 5th 2020


Strategic Partners